Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|May 1, 2005
- Volume 0 0
On-line Drug Consumers Willing to Take Risk
Advertisement
Despite lack of FDA approval, more than a third of on-line consumers said that they would purchase prescription medications. The survey, conducted by comScore Networks, found that 54% of the participants were "very concerned" about the safety of on-line drugs, compared with 30% of the respondents who were not concerned. Of the 315 respondents, 38% reported that they would purchase drugs online "that are not FDA-approved but work for me," compared with 45% who said that they would not.
Articles in this issue
over 21 years ago
Top 200 Prescription Drugs of 2004over 21 years ago
New Drugs of 2004over 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Avastin Decreases Lung Cancer Patients' Mortalityover 21 years ago
Simvastatin Improves Mortality of Heart Failure Patientsover 21 years ago
Pharma Companies Developing Antismoking Drugsover 21 years ago
Handbook Disclaimers Permit Dismissal of Pharmacistover 21 years ago
Annual Eye Exams Unnecessary for Someover 21 years ago
Safe Options for Needle Disposalover 21 years ago
Prevention Can Save $2.5 Billion AnnuallyAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
2
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
3
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
4
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
5